Does PIMECROLIMUS Cause Therapy non-responder? 13 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Therapy non-responder have been filed in association with PIMECROLIMUS (Pimecrolimus). This represents 1.0% of all adverse event reports for PIMECROLIMUS.
13
Reports of Therapy non-responder with PIMECROLIMUS
1.0%
of all PIMECROLIMUS reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy non-responder From PIMECROLIMUS?
Of the 13 reports.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMECROLIMUS. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does PIMECROLIMUS Cause?
Drug ineffective (349)
Treatment failure (139)
Psoriasis (114)
Off label use (113)
Pruritus (94)
Erythema (89)
Product use in unapproved indication (86)
Rash (82)
Application site pain (72)
Therapeutic product effect incomplete (65)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which PIMECROLIMUS Alternatives Have Lower Therapy non-responder Risk?
PIMECROLIMUS vs PIMOZIDE
PIMECROLIMUS vs PINAVERIUM
PIMECROLIMUS vs PINDOLOL
PIMECROLIMUS vs PIOGLITAZONE
PIMECROLIMUS vs PIPAMPERONE